BDNF and type 2 diabetes mellitus: Further, the intermediatory protein encoding genes, along with the drug target receptors and the BDNF, were assessed for their gene expression in PBMC, including those who were untreated T2DM (Group 1), under metformin (Group 2), under glimepiride treatment (Group 3), and the healthy control (Group 4).